WASHINGTON — Moderna on Wednesday said its new COVID-19 booster candidate, which it is hoping to get approved this fall, performed well against Omicron’s latest subvariants. The US biotech company…
WASHINGTON — US health authorities confirmed on Friday that data provided by drug-maker Moderna on the efficacy of its Covid-19 vaccine among very young children were accurate, ahead of a…
AP — Moderna’s experimental COVID-19 vaccine that combines its original shot with protection against the omicron variant appears to work, the company announced Wednesday. COVID-19 vaccine makers are studying updated…